Peter W. Sonsini - 28 Jun 2021 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Reporting relationship: 10%+ Owner
Issuer ticker: GLUE
Reported as of: 28 Jun 2021
Net transaction value: +$19,950,000
SEC form: 4
Accepted by SEC: 30 Jun 2021, 18:08:18 UTC
Prior SEC filing: 24 Jun 2021
Next SEC filing: 29 Jul 2021
Source filing: View source filing
Reporting owner signature: /s/ Sasha Keough, attorney-in-fact

Key filing fact

Peter W. Sonsini filed Form 4 for Monte Rosa Therapeutics, Inc. (GLUE) on 30 Jun 2021.

Key facts

This page summarizes Peter W. Sonsini's Form 4 filing for Monte Rosa Therapeutics, Inc. (GLUE).
7 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 30 Jun 2021, 18:08.

Change

Previous filing in this sequence was filed on 24 Jun 2021.
Current net transaction value: +$19,950,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GLUE transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +2,715,968
Change %
Price
Shares after: 2,715,968
Date: 28 Jun 2021
Ownership: See Note 2
Footnotes: F1, F2

GLUE transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +3,257,328
Change %: +120%
Price
Shares after: 5,973,296
Date: 28 Jun 2021
Ownership: See Note 2
Footnotes: F1, F2

GLUE transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +669,002
Change %: +11%
Price
Shares after: 6,642,298
Date: 28 Jun 2021
Ownership: See Note 2
Footnotes: F1, F2

GLUE transaction

Common Stock

Purchase

Transaction value: $19,950,000
Shares: +1,050,000
Change %: +16%
Price: $19.00
Shares after: 7,692,298
Date: 28 Jun 2021
Ownership: See Note 2
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GLUE transaction Derivative

Series A-2 convertible preferred stock

Conversion of derivative security

Transaction value
Shares: -9,588,725
Change %: -100%
Price
Shares after: 0
Date: 28 Jun 2021
Ownership: See Note 2
Underlying class: Common Stock
Underlying amount: 2,715,968
Exercise price
Footnotes: F1, F2

GLUE transaction Derivative

Series B convertible preferred stock

Conversion of derivative security

Transaction value
Shares: -11,500,000
Change %: -100%
Price
Shares after: 0
Date: 28 Jun 2021
Ownership: See Note 2
Underlying class: Common Stock
Underlying amount: 3,257,328
Exercise price
Footnotes: F1, F2

GLUE transaction Derivative

Series C convertible preferred Stock

Conversion of derivative security

Transaction value
Shares: -2,361,912
Change %: -100%
Price
Shares after: 0
Date: 28 Jun 2021
Ownership: See Note 2
Underlying class: Common Stock
Underlying amount: 669,002
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date.

Footnote F2

The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.